Studies
Pre-Enrolling
All Studies
Expand your treatment options and enhance your practice by integrating clinical trials. Gain access to a diverse portfolio of studies, sourced from over 20 industry sponsors, and broaden the care you can offer your community. Our tailored approach to trial matching ensures your patients are connected with studies that meet their specific needs, allowing them to explore the latest advancements in care and discover how clinical trials can directly benefit their health journey. Find available trials nearby and empower your patients with access to cutting-edge treatments.
Matador Study: An ATOMIC Consortium Analysis
MATADOR is a retrospective multi-center descriptive study that will seek to analyze the real-world population of patients with HER2-mutated advanced non-small cell lung cancer treated with Trastuzumab-Deruxtecan at clinical sites.
Chronic Obstructive Pulmonary Disease – Persephone
This is a parallel, Phase 2/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype.
Advanced Solid Tumors – Symbiotic-Lung-20
This clinical research study is investigating a new treatment approach for patients with advanced solid tumors. The primary goal is to determine if a new medicine, PF-08634404, is safe when administered alongside existing anti-cancer agents, and to understand how the body processes it.
